183 related articles for article (PubMed ID: 32026594)
1. Vasoactive intestinal peptide regulates ileal goblet cell production in mice.
Schwerdtfeger LA; Tobet SA
Physiol Rep; 2020 Feb; 8(3):e14363. PubMed ID: 32026594
[TBL] [Abstract][Full Text] [Related]
2. Intestinal and neuronal myenteric adaptations in the small intestine induced by a high-fat diet in mice.
Soares A; Beraldi EJ; Ferreira PE; Bazotte RB; Buttow NC
BMC Gastroenterol; 2015 Jan; 15():3. PubMed ID: 25609418
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats.
Keita AV; Carlsson AH; Cigéhn M; Ericson AC; McKay DM; Söderholm JD
Neurogastroenterol Motil; 2013 Jun; 25(6):e406-17. PubMed ID: 23600853
[TBL] [Abstract][Full Text] [Related]
4. The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro.
Cutler DJ; Haraura M; Reed HE; Shen S; Sheward WJ; Morrison CF; Marston HM; Harmar AJ; Piggins HD
Eur J Neurosci; 2003 Jan; 17(2):197-204. PubMed ID: 12542655
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of vasoactive intestinal polypeptide receptor 1 and 2 mRNA in murine intestinal T lymphocyte subtypes.
Qian BF; Hammarström ML; Danielsson A
J Neuroendocrinol; 2001 Sep; 13(9):818-25. PubMed ID: 11578532
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in anatomic plasticity of gut neuronal-mast cell interactions.
Schwerdtfeger LA; Tobet SA
Physiol Rep; 2021 Oct; 9(19):e15066. PubMed ID: 34605201
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease.
Lelievre V; Favrais G; Abad C; Adle-Biassette H; Lu Y; Germano PM; Cheung-Lau G; Pisegna JR; Gressens P; Lawson G; Waschek JA
Peptides; 2007 Sep; 28(9):1688-99. PubMed ID: 17606312
[TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion.
Ríos JD; Zoukhri D; Rawe IM; Hodges RR; Zieske JD; Dartt DA
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1102-11. PubMed ID: 10235543
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.
Wu X; Conlin VS; Morampudi V; Ryz NR; Nasser Y; Bhinder G; Bergstrom KS; Yu HB; Waterhouse CC; Buchan AM; Popescu OE; Gibson WT; Waschek JA; Vallance BA; Jacobson K
PLoS One; 2015; 10(5):e0125225. PubMed ID: 25932952
[TBL] [Abstract][Full Text] [Related]
10. Effect of VIP on intracellular [Ca2+], extracellular regulated kinase 1/2, and secretion in cultured rat conjunctival goblet cells.
Li D; Jiao J; Shatos MA; Hodges RR; Dartt DA
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2872-84. PubMed ID: 23518767
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation.
Vacas E; Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Schally AV; Prieto JC; Carmena MJ
Biochim Biophys Acta; 2012 Oct; 1823(10):1676-85. PubMed ID: 22728770
[TBL] [Abstract][Full Text] [Related]
12. VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.
Li JM; Darlak KA; Southerland L; Hossain MS; Jaye DL; Josephson CD; Rosenthal H; Waller EK
PLoS One; 2013; 8(5):e63381. PubMed ID: 23723978
[TBL] [Abstract][Full Text] [Related]
13. Intraepithelial lymphocytes, goblet cells and VIP-IR submucosal neurons of jejunum rats infected with Toxoplasma gondii.
Sant'Ana DM; Góis MB; Zanoni JN; da Silva AV; da Silva CJ; Araújo EJ
Int J Exp Pathol; 2012 Aug; 93(4):279-86. PubMed ID: 22804764
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
Zia H; Hida T; Jakowlew S; Birrer M; Gozes Y; Reubi JC; Fridkin M; Gozes I; Moody TW
Cancer Res; 1996 Aug; 56(15):3486-9. PubMed ID: 8758916
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
Juarranz MG; De Neef P; Robberecht P
Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
[TBL] [Abstract][Full Text] [Related]
16. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors.
Kakurai M; Fujita N; Murata S; Furukawa Y; Demitsu T; Nakagawa H
J Invest Dermatol; 2001 May; 116(5):743-9. PubMed ID: 11348464
[TBL] [Abstract][Full Text] [Related]
18. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.
Yusta B; Holland D; Waschek JA; Drucker DJ
Endocrinology; 2012 Jun; 153(6):2623-32. PubMed ID: 22535770
[TBL] [Abstract][Full Text] [Related]
19. Neuronal release of vasoactive intestinal peptide is important to astrocytic protection of neurons from glutamate toxicity.
Brown DR
Mol Cell Neurosci; 2000 May; 15(5):465-75. PubMed ID: 10833303
[TBL] [Abstract][Full Text] [Related]
20. Presence of nerves and their receptors in mouse and human conjunctival goblet cells.
Diebold Y; Ríos JD; Hodges RR; Rawe I; Dartt DA
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2270-82. PubMed ID: 11527940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
